• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
NewslettersBrainstorm Health

Juul’s CEO Steps Down. But What Comes Next?: Brainstorm Health

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
September 25, 2019, 8:13 PM ET

Hello and happy hump day, readers.

Perhaps it was inevitable in the face of lawsuits, regulatory crackdowns, reports of horrifying lung illnesses, and a general sense of unease—but Kevin Burns, CEO of the privately-held firm Juul, is stepping down from his perch.

The Juul CEO’s sudden departure is just one chapter in this rapidly unfolding story. Here’s another excerpt: The tobacco giant Altria, which bought a 35% stake in Juul last year at a reported $40 billion valuation, is no longer in talks with Philip Morris International (PMI) to bring the companies together again.

Altria spun off PMI more than a decade ago while holding on to the U.S.-based Philip Morris unit (which controls major brands such as Marlboro in America). PMI has been focused on “heat not burn” tobacco products in international markets (these are not the same things as vapes). The divergent business strategies, and the public health outcry against vaping and e-cigs, almost certainly sunk any potential deal.

But what happens next? Will PMI’s bet on heat-not-burn devices actually pay dividends in the consumer market? And, more importantly, are these devices any better from a public health perspective than the vaping products facing blowback right now?

Read on for the day’s news.

Sy Mukherjee, @the_sy_guy, sayak.mukherjee@fortune.com

DIGITAL HEALTH

Amazon is launching an employee health clinic. CNBC's Chrissy Farr (who else?) reports on Amazon's latest foray into health care, dubbed, well, Amazon Care. Farr describes it as a "virtual primary care" for employees that offers a combination of telemedicine and in-person services. (CNBC)

INDICATIONS

The flip side of the cancer drug boom. It's hard to argue that creating more cancer drugs is a bad thing. But almost everything in business and drug development comes with the possibility of adverse events—including opportunity cost. BioPharma Dive reports on the struggles of cancer drug centers to keep up with the clinical demand in an illuminating piece. (BioPharma Dive)

REQUIRED READING

How the Impeachment Process Could Affect the Stock Market, by Erik Sherman

Facebook's Big Hopes in Augmented and Virtual Reality Face Even Bigger Obstacles, by Danielle Abril

The World's Forests Are Burning—And the Damage Goes Far Beyond the Amazon, by Nicolas Rapp & Brian O'Keefe

Find past coverage. Sign up for other Fortune newsletters.

About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Newsletters

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Newsletters

NewslettersMPW Daily
Are Instagram beauty filters harming teen girls? A trial puts self-proclaimed ‘girl dad’ Mark Zuckerberg on the spot
By Emma HinchliffeFebruary 20, 2026
2 days ago
The Amazon logo seen displayed on a smartphone screen with a graph in the background.
NewslettersCFO Daily
Amazon surpasses Walmart as the largest company by revenue in the U.S. as retail’s tech era takes hold
By Sheryl EstradaFebruary 20, 2026
2 days ago
NewslettersTerm Sheet
Defy Ventures teaches entrepreneurship in prisons. It changed how I think about founders
By Allie GarfinkleFebruary 20, 2026
2 days ago
NewslettersFortune Tech
Waymo’s New York dreams are dashed—for now
By Alexei OreskovicFebruary 20, 2026
2 days ago
NewslettersCEO Daily
Amazon dethrones Walmart as No. 1 on the Fortune 500. There’s a big upside to their rivalry
By Diane BradyFebruary 20, 2026
3 days ago
CybersecurityEye on AI
AI is running out of power. Space won’t be an escape hatch for decades
By Sharon GoldmanFebruary 19, 2026
3 days ago

Most Popular

placeholder alt text
Innovation
The U.S. spent $30 billion to ditch textbooks for laptops and tablets: The result is the first generation less cognitively capable than their parents
By Sasha RogelbergFebruary 21, 2026
1 day ago
placeholder alt text
Big Tech
Peter Thiel and other tech billionaires are publicly shielding their children from the products that made them rich
By Marco Quiroz-GutierrezFebruary 21, 2026
1 day ago
placeholder alt text
Startups & Venture
'I have a chip on my shoulder.' Phoebe Gates wants her $185 million AI startup Phia to succeed with 'no ties to my privilege or my last name'
By Sydney LakeFebruary 21, 2026
1 day ago
placeholder alt text
Economy
New Fed report proves Milton Friedman and Joe Biden understood something vital about immigration—and explains why growth may sputter under Trump
By Shawn TullyFebruary 22, 2026
12 hours ago
placeholder alt text
Success
40% of Stanford undergrads receive disability accommodations—but it's become a college-wide phenomenon as Gen Z try to succeed in the current climate
By Preston ForeFebruary 21, 2026
1 day ago
placeholder alt text
Economy
Trump's sudden decision to hike his new tariff rate to 15% is 'something of an eff you' to the U.K., which thought it had a better deal for 10%
By Jason MaFebruary 21, 2026
23 hours ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.